Characteristics of lymphoid cell effector cytotoxicity mechanisms in patients with sinonasal neoplasms

  • Elizaveta M. Nazaranka International Sakharov Environmental Institute, Belarusian State University; Research Institute of Experimental and Clinical Medicine, Belarusian State Medical University
  • Natallia A. Morozova N. N. Alexandrov National Cancer Center of Belarus
  • Alesia V. Vialichka International Sakharov Environmental Institute, Belarusian State University; bResearch Institute of Experimental and Clinical Medicine, Belarusian State Medical University
  • Zhanna V. Kolyadich N. N. Alexandrov National Cancer Center of Belarus
  • Darya B. Nizheharodava International Sakharov Environmental Institute, Belarusian State University; Research Institute of Experimental and Clinical Medicine, Belarusian State Medical University

Abstract

The immune response to tumors is primarily mediated through effector cytotoxic reactions, which enable the direct removal of transformed cells in the body. Granule-mediated cytotoxicity is one of the main protective antitumor mechanism, which includes the release of lytic proteins into the immunological synapse between the effector cell and the target. Studying the features of this cytotoxic mechanism is promising for identifying molecular biomarkers that can help track the progression of tumor malignancy and develop new approaches to targeted immunotherapy. This article presents the results of LAMP-1/CD107a expression and intracellular granzyme B production by cytotoxic lymphoid cells in co-cultures with tumor cell line K562 from patients with benign and malignant sinonasal tumors, who were treated in the department of head and neck tumors of the Republican Scientific and Practical Center of Oncology and Medical Radiology named after N.N. Alexandrov in 2023-2024. The comparison group consisted of patients with polypous rhinosinusitis, the control group was represented by healthy individuals. The expression of the markers was determined by flow cytofluorometry.

The study revealed an increase in the number of NK cells and a decrease in the number of T cells in cultures in patients with benign and malignant sinonasal neoplasms compared with the control group. An increase in the CD107a expression and intracellular granzyme B production by T cells from patients with malignant sinonasal neoplasms in co-cultures with K562 as compared with the control group was established, that correlates with the degree of disease malignancy (R=0.48, p=0.009 for T-cells expressing CD107, and R=0.40, p=0.03 for cells producing granzyme B). At the same time, the CD107a expression and the granzyme B production by NK-cells in co-cultures with K562 was significantly reduced in patients with both benign and malignant neoplasms.

The obtained data indicates that effector T cells in patients with malignant sinonasal neoplasms are involved in the antitumor response, predominantly using the mechanism of granule-mediated cytotoxicity, allowing to consider subpopulations of CD107a- and granzyme B-positive T cells as potential prognostic markers of malignancy of the tumor process.

Author Biographies

Elizaveta M. Nazaranka, International Sakharov Environmental Institute, Belarusian State University; Research Institute of Experimental and Clinical Medicine, Belarusian State Medical University

master’s student at the department of immunology; junior researcher at the department of immunology and biomedicine technology, scientific research of laboratory.

Natallia A. Morozova, N. N. Alexandrov National Cancer Center of Belarus

oncologist-surgeon, at the department of head and neck tumors.

Alesia V. Vialichka, International Sakharov Environmental Institute, Belarusian State University; bResearch Institute of Experimental and Clinical Medicine, Belarusian State Medical University

postgraduate student at the department of immunology; junior researcher at the department of immunology
and biomedicine technology, scientific research of laboratory.

Zhanna V. Kolyadich, N. N. Alexandrov National Cancer Center of Belarus

doctor of science (medicine), full professor; head of the laboratory of oncopathology of the central nervous
system with a group of oncopathology of the head and neck.

Darya B. Nizheharodava, International Sakharov Environmental Institute, Belarusian State University; Research Institute of Experimental and Clinical Medicine, Belarusian State Medical University

PhD (biology), docent; associate professor at the department of immunology; leading researcher at the department of immunology and biomedicine technology, scientific research of laboratory.

References

  1. Prager I., Watzl C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. Journal of Leukocyte Biology. 2019. Vol. 105, No. 6. P. 1319–1329. DOI: 10.1002/JLB.MR0718-269R.
  2. Ham H., Medlyn M., Billadeau D.D. Locked and Loaded: Mechanisms Regulating Natural Killer Cell Lytic Granule Biogenesis and Release. Front. Immunol. 2022. Vol. 13. P. 1–19. DOI: 10.3389/fimmu.2022.871106.
  3. Baldari C.T., Valitutti S., Dustin M.L. Editorial: Mechanisms of lymphocyte mediated cytotoxicity in health and disease. Front. Immunol. 2023. Vol. 14. P. 1–3. DOI: 10.3389/fimmu.2023.1226870.
  4. Trapani J.A. Granzymes, cytotoxic granules and cell death: the early work of Dr. Jurg Tschopp. Cell Death Differ. 2012. Vol. 19, No. 1 P. 21–27. DOI: 10.1038/cdd.2011.156.
  5. Wang H., Huang Y., He J. Dual roles of granzyme B. Scand J Immunol. 2021. Vol. 94, No. 3 P. 1–19. DOI: 10.1111/sji.13086.
  6. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol. 2003. Vol. 3, No. 5 P. 361–370. DOI: 10.1038/nri1083.
  7. Cohnen A., Chiang S.C., Stojanovic A. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood. 2013. Vol. 122, No. 8. P. 1411–1418. DOI: 10.1182/blood-2012-07-441832.
  8. Johnson D.E., Burtness B., Leemans C.R. Head and neck squamous cell carcinoma. Nat Rev Dis Primers. 2020. Vol. 6, No. 1. P. 1–22. DOI: 10.1038/s41572-020-00224-3.
  9. Tan Y., Wang Z., Xu M. Oral squamous cell carcinomas: state of the field and emerging directions. Int J Oral Sci. 2023. Vol. 15, No. 1. P. 1–23. DOI: 10.1038/s41368-023-00249-w.
  10. Lisan Q., Laccourreye O., Bonfils P. Sinonasal inverted papilloma: From diagnosis to treatment. European Annals of Otorhinolaryngology, Head and Neck Diseases. 2016. Vol. 133, No. 5. P. 337–341. DOI: 10.1016/j.anorl.2016.03.006.
  11. Windon M.J., D'Souza G., Rettig E.M. Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults. Cancer. 2018. Vol. 124, No. 14. P. 2993–2999. DOI: 10.1002/cncr.31385.
  12. Re M., Gioacchini F.M., Bajraktari A. Malignant transformation of sinonasal inverted papilloma and related genetic alterations: a systematic review. Eur Arch Otorhinolaryngol. 2017. Vol. 274, No. 8. P. 2991–3000. DOI: 10.1007/s00405-017-4571-2.
  13. Peltanova B., Raudenska M., Masarik M. Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review. Mol Cancer. 2019. Vol. 18, No. 1. P. 1–24. DOI: 10.1186/s12943-019-0983-5.
  14. Guillerey C. NK Cells in the Tumor Microenvironment. Tumor Microenvironment. Springer International Publishing. 2020. Vol. 1273. P. 69–90. DOI: 10.1007/978-3-030-49270-0_4.
  15. Gutkin D.W., Shurin M.R. Clinical evaluation of systemic and local immune responses in cancer: time for integration. Cancer Immunol Immunother. 2014. Vol. 63, No. 1. P. 45–57. DOI: 10.1007/s00262-013-1480-0.
  16. Rossi F., Fredericks N., Snowden A., Next Generation Natural Killer Cells for Cancer Immunotherapy. Front. Immunol. 2022. Vol. 13. P. 1–19. DOI: 10.3389/fimmu.2022.886429.
  17. Gu J.T., Claudio N., Betts C. Characterization of the tumor immune microenvironment of sinonasal squamous-cell carcinoma. Int Forum Allergy Rhinol. 2022. Vol. 12. P. 39–50. DOI: 10.1002/alr.22867.
  18. Takahashi Y., Amit M., Gleber-Netto F.O. Evaluation of the Immune Microenvironment in Sinonasal Squamous Cell Carcinoma and Its Association with Patients’ Survival. J. Neurol. Surg. Part B Skull Base. 2021. Vol. 82, No. 2. DOI: 10.1055/s-0041-1725265.
  19. Villanueva-Fernández E., Hermsen M.A., Suárez-Fernández L., Biomarkers for Immunotherapy in Poorly Differentiated Sinonasal Tumors. Biomedicines. 2022. Vol. 10. P. 1–16. DOI: 10.3390/biomedicines10092205.
  20. García-Marín R., Reda S., Riobello C. Prognostic and Therapeutic Implications of Immune Classification by CD8+ Tumor-Infiltrating Lymphocytes and PD-L1 Expression in Sinonasal Squamous Cell Carcinoma. Int J Mol Sci. 2021. Vol. 22. P. 1–11. DOI: 10.3390/ijms22136926.
  21. Quan H., Yan L., Wang S. Clinical relevance and significance of programmed death-ligand 1 expression, tumor-infiltrating lymphocytes, and p16 status in sinonasal squamous cell carcinoma. Cancer Manag Res. 2019. Vol. 11. P. 4335-4345. DOI: 10.2147/CMAR.S201568.
  22. Malkova A.M. Laboratory biomarkers of an effective antitumor immune response. Clinical significance. Cancer Treatment and Research Communications. 2021. Vol. 29. P. 1–11. DOI: 10.1016/j.ctarc.2021.100489.
  23. Qiu X.F., Chen X. LAMP1/2 as potential diagnostic and prognostic marker for brain lower grade glioma: Medicine. 2023. Vol. 102, No. 33. P. 1–11. DOI: 10.1097/MD.0000000000034604.
  24. Sarafian V.S., Koev I., Mehterov N. LAMP-1 gene is overexpressed in high grade glioma. APMIS. 2018. Vol. 126, No. 8. P. 657–662. DOI: 10.1111/apm.12856.
  25. Wang Q., Yao J., Jin Q. LAMP1 expression is associated with poor prognosis in breast cancer. Oncol Lett. 2017. Vol. 14, No. 4. P. 4729-4735. DOI: 10.3892/ol.2017.6757.
  26. Künzli B.M., Berberat P.O., Zhu Z.W. Influences of the lysosomal associated membrane proteins (Lamp-1, Lamp-2) and Mac-2 binding protein (Mac-2-BP) on the prognosis of pancreatic carcinoma. Cancer. 2002. Vol. 94, No. 1. P. 228-39. DOI: 10.1002/cncr.10162.
  27. Furuta K., Ikeda M., Nakayama Y. Expression of lysosome-associated membrane proteins in human colorectal neoplasms and inflammatory diseases. Am J Pathol. 2001. Vol. 159, No. 2. P. 449-55. DOI: 10.1016/S0002-9440(10)61716-6.
  28. Wiechmann A., Wilde B., Tyczynski B. CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients. Front Med (Lausanne). 2021. Vol. 8. P. 1–9. DOI: 10.3389/fmed.2021.556776.
  29. Deng S., Feng X., Yang M. LAMP1 as a novel molecular biomarker to predict the prognosis of the children with autism spectrum disorder using bioinformatics approaches. Sci Rep. 2023. Vol. 3, No. 1. P. 1–10. DOI: 10.1038/s41598-023-40617-4.
  30. Krzewski K., Gil-Krzewska A., Nguyen V. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. Blood. 2013. Vol. 121, No. 23. P. 4672–4683. DOI: 10.1182/blood-2012-08-453738.
  31. Ewen C.L., Kane K.P., Bleackley R.C. A quarter century of granzyme. Cell Death Differ. 2012. Vol. 9, No. 1. P. 28–35. DOI: 10.1038/cdd.2011.153.
  32. Tibbs E., Cao X. Emerging Canonical and Non-Canonical Roles of Granzyme B in Health and Disease. Cancers. 2022. Vol. 14, No. 6. P. 1–15. DOI: 10.3390/cancers14061436.
  33. Prizment A.E., Vierkant R.A., Smyrk T.C. Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women. Cancer Epidemiology, Biomarkers & Prevention. 2017. Vol. 26, No. 4. P. 622–631. DOI: 10.1158/1055-9965.EPI-16-0641.
Published
2024-11-01
Keywords: contact cytotoxicity, lymphoid cells, lysosomal-associated membrane protein-1, granzyme B, sinonasal neoplasms, K562 cell line
How to Cite
Nazaranka, E., Morozova, N., Vialichka, A., Kolyadich, Z., & Nizheharodava, D. (2024). Characteristics of lymphoid cell effector cytotoxicity mechanisms in patients with sinonasal neoplasms. Journal of the Belarusian State University. Ecology, 3, 69-79. Retrieved from https://journals.bsu.by/index.php/ecology/article/view/6581
Issue
No 3 (2024): Journal of the Belarusian State University. Ecology
Section
Medical Ecology